DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» HBcAg
HBcAg
Producing Vaccines Against Enveloped Viruses in Plants: Making the Impossible, Difficult
Characterization of Antibodies to Human Immunodeficiency Viral Proteins in the Sera of HIV Infected and Non HIV Infected Hbsag Seropositive Patients
Enveloped Viruses Distinct from HBV Induce Dissemination of Hepatitis D Virus in Vivo
Developing a Novel Hepatitis B Core – Based Antigen Presentation System
Viral Hepatitis B: Introduction
Current Opinion in Infectious Diseases Was Launched in 1988
Will Plant-Based Vaccines Be the Answer?
Role of Humoral Immunity Against Hepatitis B Virus Core Antigen in the Pathogenesis of Acute Liver Failure
Setting New Standards for Vaccine Development & Testing
XXVI Brazilian Congress of Virology
Immunogenicity of Peptide Fusions to Hepatitis B Virus Core Antigen (Recombinant DNA/Serology/Animal Virus/Human Immunodeficiency Virus/Vaccdne) STEPHEN J
The Nucleocapsid of the Hepatitis B Virus: a Remarkable Immunogenic
HALVORSEN, B. and Qlrstavik,I.Lll Institute for Experimental
Importance of Showing Hbsag and Hbcag Positivity in the Liver For
Estudio De Linfocitos T Anérgicos En La Respuesta Inmune a Rotavirus
C. Specific Emerging Viruses to Become HIV
Testing and Serological Markers of Hepatitis B Virus
Production of Double-Layered Rotavirus-Like Particles in A
Top View
Human DNA Virus Exploitation of the MAPK-ERK Cascade
Universal Influenza a (M2) Vaccines: Antibody ELISA Kits, Recombinant Proteins, Peptides and Antibodies
Distribution of Hbcag in Hepatitis B Detected by Immunoperoxidase Staining with Three Different Preparations of Anti-Hbc Antibodies
Appendix 1 – Transmission Electron Microscopy in Virology: Principles, Preparation Methods and Rapid Diagnosis
Noelle A. Colant 2020 1
WO 2017/081110 Al 18 May 2017 (18.05.2017) P O P C T
Expression of Hbsag and Hbcag in Liver Tissue: Correlation with Disease Activity Lydia Nakopouloul, N
Lectin -Defensin, Is a Θ Retrocyclin, an Antiretroviral
Efficient Production of Chimeric Hepatitis B Virus-Like Particles
Mycobacterium Tuberculosis
Novel Concepts in Virology 2020 5–7 FEBRUARY 2020 | BARCELONA, SPAIN
Setting New Standards for Vaccine Development & Testing
Redalyc.Controlling Rotavirus-Associated Diarrhea
Viral Hepatitis Reagents for Assay Development ISO Certified
Coinoculation with Hepatitis B Surface and Core Antigen Promotes a Th1 Immune Response to a Multiepitopic Protein of HIV-1
Mutations of Glu560 Within HIV-1 Envelope Glycoprotein N-Terminal
Virology Platform
Is a Function of the Secreted Hepatitis B E Antigen to Induce Immunologic Tolerance in Utero? (Hepatitis B Virus/T Celi/Transgenic Mice/Persistent Infection) DAVID R
Biomaterials: Design, Manufacturing Services and Products
Hepatito B Viruso Šerdies Baltymo Ir Jo Mutantinių Formų Sąveika Su Žmogaus Kepenų Baltymais
Recent Progress on the Versatility of Virus-Like Particles
( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2020/0345831 A1 THESS Et Al
CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge
Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19
Hepatitis B Serologic Testing Guidance the Serologic Patterns of Chronic HBV Infection Are Varied and Complex
Peptide Inhibitors of Viral Membrane Fusion RESEARCH ARTICLE
Self-Assembling Protein Nanoparticles in the Design of Vaccines